[go: up one dir, main page]

WO2001027269A3 - Vip54 protein and related materials - Google Patents

Vip54 protein and related materials Download PDF

Info

Publication number
WO2001027269A3
WO2001027269A3 PCT/IB2000/001578 IB0001578W WO0127269A3 WO 2001027269 A3 WO2001027269 A3 WO 2001027269A3 IB 0001578 W IB0001578 W IB 0001578W WO 0127269 A3 WO0127269 A3 WO 0127269A3
Authority
WO
WIPO (PCT)
Prior art keywords
vip54
protein
detected
related materials
vaca
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2000/001578
Other languages
French (fr)
Other versions
WO2001027269A2 (en
Inventor
Bernard Marina De
Cesare Montecucco
Rino Rappuoli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GSK Vaccines SRL
Original Assignee
Chiron SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron SRL filed Critical Chiron SRL
Priority to EP00969750A priority Critical patent/EP1222268A2/en
Priority to JP2001530473A priority patent/JP2003511072A/en
Priority to CA002387188A priority patent/CA2387188A1/en
Publication of WO2001027269A2 publication Critical patent/WO2001027269A2/en
Publication of WO2001027269A3 publication Critical patent/WO2001027269A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

'VIP54' protein was identified by yeast two-hybrid screening using H.pylori VacA as bait. VIP54 is not detected in neurons, but is detected in neuroblastoma cells removed from a tumour. Furthermore, VIP54 co-distributes with vimentin and decorates intermediate filaments with a dotted pattern. The invention provides proteins comprising the amino acid sequence of VIP54, as well as related peptides, nucleic acid and antibodies. These are useful as diagnostic reagents for neuroblastoma, as markers for intermediate filaments, and for the inhibition of the VIP54/VacA interaction.
PCT/IB2000/001578 1999-10-11 2000-10-11 Vip54 protein and related materials Ceased WO2001027269A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP00969750A EP1222268A2 (en) 1999-10-11 2000-10-11 Vip54 protein and related materials
JP2001530473A JP2003511072A (en) 1999-10-11 2000-10-11 VIP54 protein and related materials
CA002387188A CA2387188A1 (en) 1999-10-11 2000-10-11 Vip54 protein and related materials

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9924060.8A GB9924060D0 (en) 1999-10-11 1999-10-11 VIP54 protein
GB9924060.8 1999-10-11

Publications (2)

Publication Number Publication Date
WO2001027269A2 WO2001027269A2 (en) 2001-04-19
WO2001027269A3 true WO2001027269A3 (en) 2001-11-22

Family

ID=10862545

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2000/001578 Ceased WO2001027269A2 (en) 1999-10-11 2000-10-11 Vip54 protein and related materials

Country Status (5)

Country Link
EP (1) EP1222268A2 (en)
JP (1) JP2003511072A (en)
CA (1) CA2387188A1 (en)
GB (1) GB9924060D0 (en)
WO (1) WO2001027269A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1792990B1 (en) 2001-05-30 2011-01-26 Chiba-Prefecture Nucleid acids isolated from neuroblastomas
GB201214007D0 (en) 2012-08-07 2012-09-19 Scancell Ltd Anti-tumour immune responses to modified self-epitopes
GB201815041D0 (en) 2018-09-14 2018-10-31 Scancell Ltd Epitopes

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993018150A1 (en) * 1992-03-02 1993-09-16 Biocine S.P.A. Helicobacter pylori proteins useful for vaccines and diagnostics
WO2000058473A2 (en) * 1999-03-31 2000-10-05 Curagen Corporation Nucleic acids including open reading frames encoding polypeptides; 'orfx'
WO2000060077A2 (en) * 1999-04-02 2000-10-12 Corixa Corporation Compounds for therapy and diagnosis of lung cancer and methods for their use

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993018150A1 (en) * 1992-03-02 1993-09-16 Biocine S.P.A. Helicobacter pylori proteins useful for vaccines and diagnostics
WO2000058473A2 (en) * 1999-03-31 2000-10-05 Curagen Corporation Nucleic acids including open reading frames encoding polypeptides; 'orfx'
WO2000060077A2 (en) * 1999-04-02 2000-10-12 Corixa Corporation Compounds for therapy and diagnosis of lung cancer and methods for their use

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL 18 April 1997 (1997-04-18), XP002172521 *
DATABASE EMBL 26 April 1999 (1999-04-26), XP002172520 *
DATABASE EMBL 9 July 1997 (1997-07-09), XP002172519 *
DE BERNARD M. ET AL.: "The VacA toxin of Helicobacter pylori identifies a new intermediate filament-interacting protein", THE EMBO JOURNAL, vol. 19, no. 1, 4 January 2000 (2000-01-04), pages 48 - 56, XP002172517 *
SANO K. ET AL.: "Novel SH3 protein encoded by the AF3p21 gene is fused to the mixed lineage leukemia protein in a therapy-related leukemia with (3;11)(p21;q23)", BLOOD, vol. 95, no. 3, 1 February 2000 (2000-02-01), pages 1066 - 1068, XP002172518 *

Also Published As

Publication number Publication date
GB9924060D0 (en) 1999-12-15
WO2001027269A2 (en) 2001-04-19
EP1222268A2 (en) 2002-07-17
JP2003511072A (en) 2003-03-25
CA2387188A1 (en) 2001-04-19

Similar Documents

Publication Publication Date Title
DE69731626D1 (en) SH3-BINDING PEPTIDES OF CORTACTIN AND THEIR USE
DE69409312T2 (en) Production and screening of highly diverse peptide banks with regard to binding activity
WO1999066025A3 (en) Mtbx protein and nucleic acid molecules and uses therefor
WO2001012659A3 (en) Human dna sequences
EP1097994A3 (en) Human bad polypeptides, encoding nucleic acids and methods of use
WO1999047656A3 (en) Nucleic acid binding proteins
WO1999064592A3 (en) Green fluorescent proteins for measuring the ph of a biological sample
CA2295999A1 (en) Nik proteins, nucleic acids and methods
CA2302147A1 (en) Methods for protein screening
SE9500023D0 (en) Method of detecting cancer
BR9912455A (en) nucleic acids encoding proteins involved in sensory transduction
CA2173102A1 (en) Dna sequence coding for a bmp receptor
WO2000019988A8 (en) NOVEL Th2-SPECIFIC MOLECULES AND USES THEREOF
EP0992584A3 (en) Purified mammalian FLT3 ligands and agonists and antagonists thereof
ATE322684T1 (en) SRC SH3 BINDING PEPTIDES AND METHOD FOR ISOLATION AND USE THEREOF
WO2001061005A3 (en) Molecules of the pyrin domain protein family and uses thereof
WO2001027269A3 (en) Vip54 protein and related materials
WO2000007024A3 (en) Method of protein analysis
CA2340888A1 (en) Novel tumor antigen protein sart-3 and tumor antigen peptide thereof
EP1132397A4 (en) 'SENSOR PROTEIN' AND ITS USE
WO2001000673A8 (en) Membrane-associated and secreted proteins and uses thereof
CA2250263A1 (en) Human netrin-1
EP1065214A4 (en) NOVEL PEPTIDES WITH PHYSIOLOGICAL ACTIVITY AND THEIR USE
WO2001018216A3 (en) 26176, a novel calpain protease and uses thereof
WO1997032022A3 (en) Canine ob protein compositions and methods

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): CA JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): CA JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2001 530473

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 2387188

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2000969750

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2000969750

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2000969750

Country of ref document: EP